“…Testing between these possibilities has been challenging in the absence of interneuron-specific molecular markers. Indeed, of the cardinal interneuron markers used to identify and selectively target sub-populations of interneurons in other regions of the brain, most are either not expressed in either the VTA or SNc, or are also expressed by sub-groups of dopamine neurons (e.g., somatostatin, cholecystokinin, vasoactive intestinal peptide, neuropeptide Y, parvalbumin, and calretinin; Hökfelt et al, 1980; Seroogy et al, 1988 , 1989; Rogers, 1992; Isaacs and Jacobowitz, 1994; Liang et al, 1996; Gonzalez-Hernandez and Rodriguez, 2000; Klink et al, 2001; Lein et al, 2007; Olson and Nestler, 2007; Dougalis et al, 2012; Merrill et al, 2015 ). One potential candidate, however, is neuronal nitric oxide synthase (nNOS).…”